Advertisement

Topics

NeoGenisis Drug Discovery Incorporated Company Profile

03:55 EDT 24th October 2017 | BioPortfolio

We are focused on the discovery of small molecule drugs on a proteome and genome-wide scale. We believe that we are the only company currently capable of delivering small molecule drug candidates for virtually every medically important protein encoded by the human genome and that the rate at which we are forming discovery alliances validates the vast opportunity presented by the convergence of our technologies with genomics and proteomics. We are leveraging our chemical genomics strategy through collaborations with biotechnology and pharmaceutical companies as well as our internal discovery efforts.

Location

840 Memorial Drive, 5th Florr
Cambridge
MA
02139
United States of America

Contact

Phone: 617 868 1500
Email: info@neogenisis.com


News Articles [1192 Associated News Articles listed on BioPortfolio]

Consortium Applies Quantum Computing to Drug Discovery for Neurological Diseases

NewsMolecular comparison is a crucial part of early-phase drug design and discovery.

Pharmacophore modeling and applications in drug discovery: challenges and recent advances

The most downloaded article from Drug Discovery Today in Q2 2010 was by Sheng-Yong Yang and deals with the application of pharmacophore modeling to drug discovery.

Cancer research: 3-D models accommodate better precision in drug discovery

The field of cancer research is moving rapidly toward three-dimensional (3D) laboratory cultures because 3D models can speed drug discovery and better predict the efficacy of using certain drug therap...

GlaxoSmithKline and Exscientia enter strategic drug discovery collaboration

Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, has entered into a strategic drug discovery collaboration with GlaxoSmithKline (GSK). During t...

BenevolentAI hires Ian Churcher as VP of Drug Discovery & Preclinical Development

BenevolentAI, one of the world’s largest private AI companies, has hired Dr. Ian Churcher as its new VP of Drug Discovery & Preclinical Development of its bioscience subsidiary BenevolentBio. Ia...

Pfizer Unit and Drug Discovery Foundation Co-Funding Alzheimer's Project

NewsAlzheimer's Drug Discovery Foundation and Pfizer's Centers for Therapeutic Innovation co-fund new Alzheimer's project. Cross-sector collaboration aimed at speeding the development of potential the...

Target class drug discovery

Selection of molecular targets based on disease understanding is a dominant paradigm in drug discovery. We argue that a focus on classes of targets with central roles in biology provides a complimenta...

Numerate, Takeda partner on AI-driven drug discovery

Numerate, a computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, announced the formation of a multi-year agreement with Ta...

PubMed Articles [2989 Associated PubMed Articles listed on BioPortfolio]

Role of Academic Drug Discovery in the Quest for New CNS Therapeutics.

There was a greater than 50% decline in central nervous system (CNS) drug discovery and development programs by major pharmaceutical companies from 2009 to 2014. This decline was paralleled by a rise ...

From machine learning to deep learning: progress in machine intelligence for rational drug discovery.

Machine intelligence, which is normally presented as artificial intelligence, refers to the intelligence exhibited by computers. In the history of rational drug discovery, various machine intelligence...

Fragment-Based Drug Discovery of Phosphodiesterase Inhibitors.

Phosphodiesterases are proving to be fruitful targets for drug discovery. At the same time fragment-based drug discovery has matured into a powerful and widely applied technique. In this communication...

Allosteric Tuning of Caspase-7: a Fragment-Based Drug Discovery Approach.

The caspase family of cysteine proteases are highly sought after drug targets due to their essential roles in apoptosis, proliferation and inflammation pathways. High throughput screening efforts to d...

Kinetics for Drug Discovery: an industry-driven effort to target drug residence time.

A considerable number of approved drugs show non-equilibrium binding characteristics, emphasizing the potential role of drug residence times for in vivo efficacy. Therefore, a detailed understanding o...

Clinical Trials [2020 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Biologic Basis of Liver Cancer From Chronic Hepatitis B

The focus of the study is to identify viral factors and host immune responses that differentiate HBV-related HCC patients from HBV patients who have not progressed to HCC. To that end, the...

Companies [2320 Associated Companies listed on BioPortfolio]

NeoGenisis Drug Discovery Incorporated

We are focused on the discovery of small molecule drugs on a proteome and genome-wide scale. We believe that we are the only company currently capable of delivering small molecule drug candidates for ...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Argenta Discovery Ltd.

Argenta Discovery is a privately held drug discovery company, applying its integrated medicinal chemistry, biology, ADMET and CADD expertise to drive drug discovery programmes. Argenta has a successfu...

Drug Discovery Industr

Welcome to Drug Discovery Online, the first Internet site devoted exclusively to drug discovery and early-stage drug development.Drug Discovery Online covers drug discovery like no other Internet site...

Beryllium

Beryllium is shaping the future of collaborative drug discovery. Our proven teams of drug discovery professionals are passionate about unlocking the therapeutic potential of both ...

More Information about "NeoGenisis Drug Discovery Incorporated" on BioPortfolio

We have published hundreds of NeoGenisis Drug Discovery Incorporated news stories on BioPortfolio along with dozens of NeoGenisis Drug Discovery Incorporated Clinical Trials and PubMed Articles about NeoGenisis Drug Discovery Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeoGenisis Drug Discovery Incorporated Companies in our database. You can also find out about relevant NeoGenisis Drug Discovery Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record